The relationship between the antifibrillatory and hemodynamic effects of propranolol and timolol was tested in 32 dogs divided into three groups. In closed-chest animals (group 1), the maximal increase of the ventricular fibrillation threshold (VFT) from the control state was 67.3 ± 22.6% ( n = 5, p < 0.01) for propranolol and 95.8 ± 18.8% ( n = 9, p < 0.005) for timolol. These effects were paralleled by a decrease in the cardiac index of 34.7 ± 10.2% ( p < 0.05) and 32.5 ± 9.4% ( p < 0.02) for propranolol and timolol, respectively. The mean systemic arterial pressure (SAP) also decreased by 25.0 ± 8.8% ( p < 0.05) and 19.2 ± 5.1% ( p < 0.01). In open-chest animals (group 2), timolol increased the VFT by 86.6 ± 27% (n = 5, p < 0.05) and decreased the cardiac index by 57.3 ± 6.3% ( p < 0.005) and the mean SAP by 28.5 ± 2.9% ( p < 0.02). In open-chest animals with stabilized peripheral hemodynamics (group 3), VFT increased by 354 ± 130% ( p < 0.05) and 437 ± 144% ( p < 0.05) after the maximal administered doses of propranolol ( n = 6) and timolol ( n = 7), respectively. These results suggest that the electrophysiologic and hemodynamic effects of beta blockade are parallel and interdependent, with the hemodynamic deterioration markedly blunting the beneficial electrophysiologic effects.
Read full abstract